Ocean Biomedical, Inc.
OCEA· OTC
Filed May 15, 2025 · 10-Q · 45 days after period end · 0001641172-25-011080
| Metric | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 |
|---|---|---|---|---|
| Net Income | -$8.24M | $13.00M | -$72.09M | -$165.71K |
| EPS Diluted | -$0.09 | $0.48 | -$2.90 | -$0.23 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Ocean Biomedical, Inc. · CIK 1869974 · Engraved from SEC EDGAR
ended Mar 31, 2025 · filed May 15, 2025 · 45 d after period end